Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Special Drug Use Investigation (Retrospective) for Arixtra® (Fondaparinux) Venous Thromboembolism Treatment (Over 100kg)

NCT01428544 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01428544
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01428544 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Special Drug Use Investigation (Retrospective) for Arixtra® (Fondaparinux) Venous Thromboembolism Treatment (Over 100kg)
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Completed
Start date
March 31, 2012
Completion date
June 30, 2015
Enrollment
5 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ataxia